The immune system plays a dual role in tumor dynamics. On one hand, it can recognize and destroy cancer cells through immune surveillance. On the other hand, tumors can evade immune detection by creating an immunosuppressive microenvironment or by expressing immune checkpoint molecules that inhibit immune responses. Immunotherapies, such as checkpoint inhibitors and CAR-T cells, are designed to enhance the immune system's ability to fight cancer.
